← SearchUsing EFdA to target HIV from various subtypes:Inhibition mechanism and efficacy against clinical resistant mutants$46,036F31FY2021AINIHEmory University, Atlanta GAInvestigatorsMaria CilentocontactLinked publications, trials & patentsPaper 37896768Paper 35746673Paper 34516245View original record on NIH RePORTER →